Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease

Transplant Proc. 2002 Jun;34(4):1178-81. doi: 10.1016/s0041-1345(02)02754-9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD / immunology
  • Antigens, CD20 / immunology*
  • Black or African American
  • California
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / immunology*
  • Lymphoproliferative Disorders / drug therapy*
  • Male
  • Postoperative Complications / drug therapy*
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD
  • Antigens, CD20
  • Immunosuppressive Agents
  • Rituximab